Empowering patients as partners – New podcast episode

In focus / 06 September 2023

A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?


In this special long-reads episode, Manal Younus elaborates on her work on patient engagement, and how their perspective impacts drug safety monitoring and pharmacovigilance. Stay tuned for their discussion after the article, which goes into detail on how healthcare providers can more effectively engage patients, how patients themselves can become more involved in drug safety monitoring, and how the patient’s voice impacted pharmacovigilance of a specific drug: valproate.

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.

You may also like


It takes a community to make medicines safer for all

The ‘PV in the Community’ special interest group explores how a community-focused approach can enhance medication safety and foster a more patient-centric pharmacovigilance system.

10 March 2025

Pharmacovigilance as a key tool in the One Health approach to AMR

The One Health approach aims to combat resistant organisms spreading between humans, animals and environments, safeguarding antimicrobials for the future.

21 May 2025

Orphan Drugs: Hope for rare disease communities

Orphan drug monitoring emerges as a critical lifeline for rare diseases, offering hope to patients with uncommon medical conditions.

14 April 2025